<DOC>
	<DOCNO>NCT00330434</DOCNO>
	<brief_summary>The two purpose study 1. determine effect chronic moderate/heavy drink alcoholic beverage 1. blood level bupropion chlorzoxazone major breakdown product blood 2. stimulant effect bupropion 2. determine effect normal common ( 25 % frequency ) genetic variation specific liver enzyme ( breaks bupropion ) 1. blood level bupropion major breakdown product blood 2. stimulant effect bupropion . Two group volunteer recruit study : 1. volunteer drink moderate heavy amount alcohol frequently 2. volunteer usually drink alcohol . Volunteers NOT ask change drinking ( nondrinking ) habit study .</brief_summary>
	<brief_title>Effect Ethanol Genetic Polymorphisms Bupropion Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Chlorzoxazone</mesh_term>
	<criteria>Healthy adult 21 55 year age . Either 1 ) Moderatetoheavy drinker drink average 14 less 28 drink per week ; OR 2 ) adult normally abstain drink alcohol . Participants currently take prescription medication ( include oral contraceptive ) Pregnancy Body mass index ( BMI ) great 30 History seizure eat disorder</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Alcohol</keyword>
	<keyword>Bupropion</keyword>
	<keyword>Chlorzoxazone</keyword>
	<keyword>Interaction</keyword>
	<keyword>Induction</keyword>
	<keyword>Depression</keyword>
	<keyword>Smoking</keyword>
	<keyword>Drinking</keyword>
	<keyword>Cytochrome P450 Enzyme</keyword>
	<keyword>CYP2B6</keyword>
	<keyword>CYP2E1</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Boston</keyword>
	<keyword>Tufts University</keyword>
</DOC>